Etoposide Antitumor reagent. Topoisomerase II inhibitor. Induces by FasL. Activates p53 resulting in upregulated expression of TRAIL-R2 (DR5) and Bak to overcome TRAIL resistance in Bax-deficient human colon carcinoma cancer cells.
* Listed below are a few published articles demonstrating the use of our Etoposide. Inquire for a full list of references.